Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (8)
  • News item (6)
  • Blog post (3)
  • Subject (2)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) October 2025 (11)
  • (-) June 2025 (8)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • December 2025 (21)
  • November 2025 (16)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • December 2024 (13)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (17)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • April 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (3)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (15)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • Nanotechnology and advanced materials (3)
  • COVID-19 (2)
  • Flu and flu vaccine (2)
  • Bestrijdingsmiddelen (1)
  • Coronaviruses (1)
  • Food and Nutrition (1)
  • Heat (1)
  • Infectious Disease Control (1)
  • Pneumococci (1)
  • Respiratory infections (1)

19 search results

You searched for these word(s): risk assessment
  • Lower risk of post-COVID after SARS-CoV-2 infection

    https://www.rivm.nl/en/news/lower-risk-of-post-covid-after-sars-cov-2-infection

    … The risk of developing long-term symptoms after a SARS-CoV-2 … infection are also known as post-COVID or Long COVID. The risk of long-term symptoms after COVID-19 is expected to … nine months, this difference had vanished. Causes for lower risk of post-COVID Many people in the Netherlands have …

    Publication date: 10-07-2025
  • National Heatwave Plan evaluation: substantial attenuation in risk of dying from heat since 2010

    https://www.rivm.nl/en/news/national-heatwave-plan-evaluation-substantial-attenuation-in-risk-of-dying-from-heat-since

    … The risk of dying on hot days has substantially attenuated since … Heatwave Plan has helped people become more aware of the risks associated with heat. According to the researchers, … this is a possible explanation for the decrease. The risk of dying on hot days, however, remains higher than …

    Publication date: 06-02-2025
  • A new Adverse Outcome Pathway to assess if nanomaterials may compromise gut barrier integrity

    https://www.rivm.nl/en/weblog/new-adverse-outcome-pathway-to-assess-if-nanomaterials-may-compromise-gut-barrier-integrity

    … the AOP and associated testing methods are relevant for the risk assessment of NMs. An AOP for a compromised gut barrier … methods has the potential to be highly relevant for the risk assessment of NMs. …

    Publication date: 06-12-2025
  • Out of REACH? Regulatory challenges for multicomponent nanomaterials

    https://www.rivm.nl/en/weblog/out-of-reach-regulatory-challenges-for-multicomponent-nanomaterials

    … uncertainties remain regarding their categorisation and assessment. More precise definitions and guidelines are … their solubility and dissolution, it is unclear whether the assessment should focus on a single or multiple components. …

    Publication date: 06-12-2025
  • It is almost time for your seasonal flu vaccine

    https://www.rivm.nl/en/news/it-is-almost-time-for-your-seasonal-flu-vaccine

    … of this vaccine is to protect people with additional risk, for example due to being 60 years of age or older or …

    Publication date: 10-15-2025
  • The 'SPARK' project studying pesticides and Parkinson’s

    https://www.rivm.nl/en/bestrijdingsmiddelen/spark

    … about the SPARK project (Strategies for regulatory assessment of Parkinson’s disease). … the current OECD guideline studies for regulatory safety assessment to predict whether a chemical substance could …

    Publication date: 06-11-2025
  • Safe use of purified wastewater in agriculture and horticulture

    https://www.rivm.nl/en/news/safe-use-of-purified-wastewater-in-agriculture-and-horticulture

    … clean and safe. That is why RIVM has developed an assessment framework to test whether the use of purified … ecosystem. Air and drinking water   There is a small risk of people becoming ill when they come into contact with … water is produced from groundwater. This is because of the risk that pathogens may end up in the drinking water through …

    Publication date: 06-25-2025
  • Publications Additional research into (micro)nutrients

    https://www.rivm.nl/en/node/244591

    … on sodium intake from processed foods 2015 Addressing the risk of inadequate and excessive micronutrient intakes: … too low and too high population intakes 2013 Integrated risk-benefit analyses: method development with folic acid as …                                                       Year Risk-benefit analyses: needs and applications in the …

    Publication date: 10-22-2025
  • Privacy Statement for Infectious Disease Diagnostics

    https://www.rivm.nl/en/privacy/privacy-statement-for-infectious-disease-diagnostics

    … on which RIVM received the sample Test type Test result Assessment of the result Determining potential public health risks Whose personal data does RIVM use? For the purpose of … of infectious disease involved – for example if there is a risk that the symptoms may recur at some future point, …

    Publication date: 10-21-2025
  • K. (Kylie) Ainslie, PhD

    https://www.rivm.nl/en/about-rivm/knowledge-and-expertise/experts-and-expertise/k-kylie-ainslie-phd

    … Imperial COVID-19 Response Team and part of the Real-time Assessment of Community Transmission (REACT) study …

    Publication date: 06-04-2025
  • New SARS-CoV-2 variant causes hardly any difference in symptoms

    https://www.rivm.nl/en/news/new-sars-cov-2-variant-causes-hardly-any-difference-in-symptoms

    … they also sent in a nose and throat swab for further assessment. New variants are not automatically more severe …

    Publication date: 10-17-2025
  • Respiratory infections now in season

    https://www.rivm.nl/en/news/respiratory-infections-now-in-season-2025

    … muscle pain, headache or tiredness. Some people are more at risk A person who has a respiratory infection can pass it on … very young children. COVID-19 and flu cause an additional risk of serious respiratory infection for older people and …

    Publication date: 10-03-2025
  • Privacy statement for the implementation of tasks legally assigned to RIVM for the purpose of infectious disease control

    https://www.rivm.nl/en/privacy/privacy-statement-implementation-tasks-legally-assigned-infectious-disease-control

    … disease with high-impact consequences and a major risk of spreading, such as measles. Doctors are required to … in a systematic manner. RIVM also uses data to identify risk factors and risk groups, research the effects of measures, and determine …

    Publication date: 10-21-2025
  • Oropouche fever

    https://www.rivm.nl/en/topics/oropouche-fever

    … virus during pregnancy could potentially increase the risk of a miscarriage or stillbirth, or birth defects in the …

    Publication date: 06-02-2025
  • Diphtheria

    https://www.rivm.nl/en/diphtheria

    … become very ill from diphtheria? Some people have a higher risk of severe disease: Children under 5 years old People …

    Publication date: 10-07-2025
  • Annual reporting on surveillance of acute respiratory infections 2024/2025 - COVID-19

    https://www.rivm.nl/en/coronavirus-covid-19/annual-reporting-2024-2025-covid-19

    … vaccination for people aged 60 and older and specific risk groups ran from 16 September to 6 December 2024. The …

    Publication date: 10-30-2025
  • UK workshops foster collaboration for safe and sustainable innovation in advanced materials

    https://www.rivm.nl/en/weblog/uk-workshops-foster-collaboration-for-safe-and-sustainable-innovation-in-advanced-materials

    … the need for a “ governance structure to manage the risk and sustainability of advanced materials ”, and …

    Publication date: 06-12-2025
  • Annual reporting on surveillance of acute respiratory infections 2024/2025 - Influenza

    https://www.rivm.nl/en/flu-and-flu-vaccine/facts-and-figures/annual-reporting-surveillance-2024-2025

    … used for treatment, only for people with a very high risk of becoming seriously ill from influenza. Among most of …

    Publication date: 10-30-2025
  • Privacy statement on research involving human subjects

    https://www.rivm.nl/en/privacy/privacy-statement-on-research-involving-human-subjects

    … Or it could be research on the health impacts of high-risk substances, environmental incidents or diet and …

    Publication date: 10-21-2025

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon